Related Experiment Videos
Progressive systemic sclerosis: radionuclide esophageal scintigraphy and manometry
Radiology
|July 1, 1986
Summary
Radionuclide esophageal scintigraphy (RES) is a reliable tool for assessing esophageal issues in progressive systemic sclerosis (PSS). It effectively detects and stages disease severity, correlating well with manometry findings.
Area of Science:
- Gastroenterology
- Rheumatology
- Nuclear Medicine
Background:
- Progressive systemic sclerosis (PSS) frequently involves esophageal dysfunction.
- Accurate assessment of esophageal involvement is crucial for managing PSS patients.
Purpose of the Study:
- To prospectively evaluate esophageal involvement and disease severity in PSS patients using radionuclide esophageal scintigraphy (RES) and manometry.
- To determine the correlation between RES and manometry findings in PSS.
Main Methods:
- 11 patients with PSS underwent RES and esophageal manometry.
- RES quantitation included percentage of esophageal emptying at 30 seconds.
- Manometry measured proximal, distal, and lower esophageal sphincter (LES) pressures.
Main Results:
- All 11 patients exhibited abnormal findings on both RES and manometry.
- High correlations were observed between RES emptying percentage and distal esophageal pressure (r = .86) and LES pressure (r = .79).
- No significant correlation was found between RES emptying and proximal esophageal pressure (r = .28).
Conclusions:
- RES is a safe, simple, and well-accepted procedure for evaluating esophageal involvement in PSS.
- RES can be utilized as a substitute for manometry in detecting and staging esophageal disease in PSS.
- RES findings correlate significantly with key manometric parameters of esophageal function in PSS.